Newstral
Article
thelocal.ch on 2018-03-27 11:51
Swiss pharma Novartis sells stake in joint venture to GSK for $13bn
Related news
Novartis sells joint venture stake to GSK for $13 billionsanluisobispo.com
- FNovartis sells stake in joint venture to GSK for $13bnft.com
Novartis sells stake in consumer business to GSK for $13bnbizjournals.com
- FNovartis sells stake in consumer unit to GSK for $13bnft.com
Novartis sells consumer healthcare division to GSK in $13bn dealtimesofmalta.com
GSK & Novartis Try Swapping SuccessWHIO
- WGSK, Novartis wrap up $21B asset swap, form joint venturewraltechwire.com
- NGSK, Pfizer team on over-the-counter drug joint venturenypost.com
- FGSK-Novartis deal ‘a model’ for industryft.com
GSK sees drop in earnings after asset swap with Novartisreviewtimes.com
- FGSK to sell Aspen stake for almost £574mft.com
Swiss pharma giant Novartis holds off US price hikes amidst pressure from President Trumpthelocal.ch
GSK turns around sales of former Novartis meningitis vaccinenewsobserver.com
Swiss pharma Novartis sees drop in profitsthelocal.ch
Ionis signs large pharma deal with Novartissandiegouniontribune.com